Contact: Karen Harris
FOR IMMEDIATE RELEASE
12 P.M. EDT, August 15, 2012
BIOMEDICA DIAGNOSTICS COMPLETES MANUFACTURING EXPANSION
WINDSOR, NS, AUGUST 15, 2012: BioMedica Diagnostics Inc. celebrates the grand opening of its manufacturing facility in Windsor NS. The investment of fully automated equipment increases productivity by 150% and more than triples production capacity of QuikCoag™ branded and OEM blood coagulation reagents.
This event marks the completion of a project that was awarded in early 2011 and is expected to create up to 10 new positions bringing the total number of employees at BioMedica in Windsor to more than 25. The company draws a significant proportion of its current employees from the local community.
BioMedica exports its products internationally to over 50 countries. The additional capacity to produce higher quality products in sufficient volume will enable BioMedica to reach growing demands in markets such as Europe, China, Latin America and South East Asia.
The Honourable Bernard Valcourt, Associate Minister of National Defence and Minister of State (Atlantic Canada Opportunities Agency) was on hand to officially open the facility with the unveiling of a commemorative plaque. Marli MacNeil, CEO BioNova was Master of Ceremonies for the event. The Honourable Minister Percy Paris (Province of Nova Scotia), Dr. Bradley (NRC), Jeff Mullen (ACOA), dignitaries from the Town of Windsor and Municipality of West Hants and representatives from the Government, Scientific and Business community were on hand to celebrate the Official Opening.
ABOUT BIOMEDICA DIAGNOSTICS
BioMedica Diagnostics Inc. is a leading Canadian Biotechnology company and manufacturer of QuikCoag™ Blood Coagulation Reagents. Internationally recognized for its dedicated focus of providing Affordable Medical Diagnostic Solutions to emerging economies of the world, BioMedica Diagnostics Inc. is a privately held company under joint ownership by Scotia Investments Ltd. and Subiaco Holdings Ltd.